The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells

Human Molecular Genetics

Volumn 15, Issue 4, 2006, Pages 625-635

  Gillingwater, Thomas H ^a   Wishart, Thomas M ^a   Chen, Philip E ^a   Haley, Jane E ^a   Robertson, Kevin ^a   MacDonald, Stephen H F ^a   Middleton, Susan ^a   Wawrowski, Kolja ^b   Shipston, Michael J ^a   Melmed, Shlomo ^b   Wyllie, David J A ^a   Skehel, Paul A ^a   Coleman, Michael P ^c   Ribchester, Richard R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^c BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; BRAIN PROTEIN; MESSENGER RNA; SECURIN; UNCLASSIFIED DRUG; WALLERIAN DEGENERATION PROTEIN; ERYTHROID DIFFERENTIATION REGULATOR 1, MOUSE; HYBRID PROTEIN; MEMBRANE PROTEIN; NERVE PROTEIN; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NMNAT1 PROTEIN, MOUSE; PITUITARY TUMOR TRANSFORMING PROTEINS; PITUITARY TUMOR-TRANSFORMING PROTEINS; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBE4B PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE; UBIQUITINATION FACTOR E4B, HUMAN; WLD PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CEREBELLUM; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; MICROARRAY ANALYSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURAL HOMOLOGY; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; INJURY; METABOLISM; MOUSE; NERVE CELL; NERVE DEGENERATION; TRANSGENIC MOUSE;

ANIMALIA; WALLERIA;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEURONS; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; WALLERIAN DEGENERATION; WOUNDS AND INJURIES;

EID: 32144434891     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi478     Document Type: Article

References (44)

1. S mutant mouse. J. Physiol., 534, 627-639.
2. Coleman, M.P. and Ribchester, R.R. (2004) Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. Curr. Drug. Targets, 3, 227-238.
3. S) nerves. BMC Neurosci., 6, 6.
4. Miledi, R. and Slater, C.R. (1970) On the degeneration of rat neuromuscular junctions after nerve section. J. Physiol., 207, 507-528.
5. Lunn, E.R., Perry, V.H., Brown, M.C., Rosen, H. and Gordon, S. (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci., 1, 27-33.
6. Lyon, M.F., Ogunkolade, B.W., Brown, M.C., Atherton, D.J. and Perry, V.H. (1993) A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc. Natl Acad. Sci. USA, 90, 9717-9720.
7. Perry, V.H., Brown, M.C. and Lunn, E.R. (1991) Very slow retrograde and Wallerian degeneration in the CNS of C57BL/Ola mice. Eur. J. Neurosci., 3, 102-105.
8. Ribchester, R.R., Tsao, J.W., Barry, J.A., Asgari-Jirhandeh, N., Perry, V.H. and Brown, M.C. (1995) Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS). Eur. J. Neurosci., 1, 1641-1650.
9. Mack, T.G.A., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T.H., Court, F., Conforti, L., et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci., 4, 1199-1206.
10. S mutant and Ube4b/Nmnat transgenic mice. J. Physiol., 543, 739-755.
11. Perry, V.H., Brown, M.C., Lunn, E.R., Tree, P. and Gordon, S. (1990) Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve. Eur. J. Neurosci., 2, 802-808.
12. Deckwerth, T.L. and Johnson, E.M. (1994) Neurites can remain viable after the destruction of the neuronal soma by programmed cell death. Dev. Biol., 165, 63-72.
13. Buckmaster, E.A., Perry, V.H. and Brown, M.C. (1995) The rate of Wallerian degeneration in cultured neurons from wild type and C57BL/WldS mice depends on time in culture and may be extended in the presence of elevated K+ levels. Eur. J. Neurosci., 7, 1596-1602.
14. S mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J. Neurosci., 23, 2833-2839.
15. Ferri, A., Sanes, J.R., Coleman, M.P., Cunningham, J.M. and Kato, A.C. (2003) Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol., 13, 669-673.
16. S-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr. Biol., 14, 326-330.
17. S mutant mice. J. Cereb. Blood Flow. Metab., 24, 62-66.
18. S, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain, 128, 405-416.
19. S does not attenuate mutant SOD1-mediated motor neuron disease. Neuromol. Med., 5, 193-203.
20. Conforti, L., Tarlton, A., Mack, T.G., Mi, W., Buckmaster, E.A., Wagner, D., Perry, V.H. and Coleman, M.P. (2000) A Ufd2/D4Colele chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc. Natl Acad. Sci. USA, 97, 11377-11382.
21. S) with improved preservation of neuromuscular synapses. Eur. J. Neurosci., 21, 271-277.
22. Zou, H., McGarry, T.J, Bernal, T. and Kirschner, M.W. (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science, 285, 418-422.
23. Yu, R., Lu, W., Chen, J., McCabe, C.J. and Melmed, S. (2003) Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology, 144, 4991-4998.
24. Dormer, P., Spitzer, E. and Moller, W. (2004) EDR is a stress-related survival factor from stroma and other tissues acting on early haematopoietic progenitors (E-Mix). Cytokine, 27, 47-57.
25. Datson, N.A., Meijer, L., Steenbergen, P.J., Morsink, M.C., van der Laan, S., Meijer, O.C. and de Kloet, E.R. (2004) Expression profiling in laser-microdissected hippocampal subregions in rat brain reveals large subregion-specific differences in expression. Eur. J. Neurosci., 20, 2541-2554.
26. Llinás, R.R. (1975) The cortex of the cerebellum. Sci. Am., 232, 56-71.
27. Mammalian Gene Collection (MGC) Program Team (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl Acad. Sci. USA, 99, 16899-16903.
28. Peng, G.H., Ahmad, O., Ahmad, F., Liu, J. and Chen, S. (2005) The photoreceptor-specific nuclear receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone genes. Hum. Mol. Genet., 14, 747-764.
29. Croxen, R., Hatton, C., Shelley, C., Brydson, M., Chauplannaz, G., Oosterhuis, H., Vincent, A., Newsom-Davis, J., Colquhoun, D. and Beeson, D. (2002) Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology, 59, 162-168.
30. Lang, B., Pinto, A., Giovannini, P., Newsom-Davis, J. and Vincent, A. (2003) Pathogenic autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann. NY Acad. Sci., 998, 187-195.
31. Araki, T., Sasaki, Y. and Milbrandt, J. (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science, 305, 1010-1013.
32. Wang, J., Zhai, Q., Chen, Y., Lin, E., Gu, W., McBurney, M.W. and He, Z. (2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J. Cell. Biol., 170, 349-355.
33. Veerkamp, J.H. and Zimmerman, A.W. (2001) Fatty acid-binding proteins of nervous tissue. J. Mol. Neurosci., 16, 133-142.
34. Wang, Z., Yu, R. and Melmed, S. (2001) Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol. Endocrinol., 15, 1870-1879.
35. Cashman, N.R., Durham, H.D., Blusztajn, J.K., Oda, K., Tabira, T., Shaw, I.T., Dahrouge, S. and Antel, J.P. (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn., 194, 209-221.
36. Usuki, S., Ren, J., Utsunomiya, I., Cashman, N.R., Inokuchi, J. and Miyatake, T. (2001) GM2 ganglioside regulates the function of ciliary neurotrophic factor receptor in murine immortalized motor neuron-like cells (NSC-34). Neurochem. Res., 26, 375-382.
37. Steward, O. and Trimmer, P.A. (1997) Genetic influences on cellular reactions to CNS injury: The reactive response of astrocytes in denervated neuropil regions in mice carrying a mutation (Wld(S)) that causes delayed Wallerian degeneration. J. Comp. Neurol., 380, 70-81.
38. Raff, M.C., Whitmore, A.V. and Finn, J.T. (2002) Axonal destruction and neurodegeneration. Science, 296, 868-871.
39. Coleman, M.P. and Perry, V.H. (2002) Axon pathology in neurological disease: A neglected therapeutic target. Trends Neurosci., 25, 532-537.
40. Zhai, Q., Wang, J., Kim, A., Liu, Q., Watts, R., Hoopfer, E., Mitchison, T., Luo, L. and He, Z. (2003) Involvement of the ubiquitin-proteasome system in the early stages of Wallerian degeneration. Neuron, 39, 217-225.
41. Korhonen, L. and Lindholm, D. (2004) The ubiquitin proteasome system in synaptic and axonal degeneration: A new twist to an old cycle. J. Cell. Biol., 165, 27-30.
42. Zhang, H., Wang, Q., Kajino, K. and Greene, M.I. (2000) VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells. DNA Cell. Biol., 19, 253-263.
43. Kernochan, L.E., Russo, M.L., Woodling, N.S., Huynh, T.N., Avila, A.M., Fischbeck, K.H. and Sumner, C.J. (2005) The role of histone acetylation in SMN gene expression. Hum. Mol. Genet., 14, 1171-1182.
44. 2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J. Neurosci., 25, 4279-4287.